Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Humoral theory of transplantation
PI Terasaki - American Journal of Transplantation, 2003 - Elsevier
According to the humoral theory of transplantation, antibodies cause allograft rejection.
Publications are cited showing that antibodies:(1) cause hyperacute kidney rejection,(2) …
Publications are cited showing that antibodies:(1) cause hyperacute kidney rejection,(2) …
Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications
S Itescu, R John - The Annals of thoracic surgery, 2003 - Elsevier
The unquestionable clinical success of left ventricular assist device (LVAD) implantation
has, nevertheless, been accompanied by complications arising from interactions between …
has, nevertheless, been accompanied by complications arising from interactions between …
Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal …
SC Jordan, D Tyan, D Stablein… - Journal of the …, 2004 - journals.lww.com
Reported are the reduction of anti-HLA antibody levels and improvement of transplant rates
by intravenous immunoglobulin (IVIG) in a randomized, double-blind, placebo-controlled …
by intravenous immunoglobulin (IVIG) in a randomized, double-blind, placebo-controlled …
[HTML][HTML] Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg)
D Glotz, C Antoine, P Julia… - American Journal of …, 2002 - Elsevier
Transplantation of patients possessing antibodies against allo‐HLA antigens can be
delayed for years. We have shown that administration of intravenous immunoglobulins (IVIg) …
delayed for years. We have shown that administration of intravenous immunoglobulins (IVIg) …
Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft …
SC Jordan, AW Quartel, LSC Czer, D Admon… - …, 1998 - journals.lww.com
Background. Intravenous gammaglobulin (IVIG) contains anti-idiotypic antibodies that are
potent inhibitors of HLA-specific alloantibodies in vitro and in vivo. In addition, highly HLA …
potent inhibitors of HLA-specific alloantibodies in vitro and in vivo. In addition, highly HLA …
Intravenous immune globulin in the therapy of peripartum cardiomyopathy
OBJECTIVES We sought to evaluate the effect of therapy with intravenous immune globulin
on recovery of left ventricular function in women presenting with peripartum cardiomyopathy …
on recovery of left ventricular function in women presenting with peripartum cardiomyopathy …
Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver …
SC Jordan, A Vo, S Bunnapradist, M Toyoda… - …, 2003 - journals.lww.com
Background. Sensitization to human leukocyte antigens (HLA) is a significant barrier to
transplantation. Currently, no proven therapy exists to improve access to transplantation for …
transplantation. Currently, no proven therapy exists to improve access to transplantation for …
Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device …
R John, K Lietz, E Burke, J Ankersmit, D Mancini… - Circulation, 1999 - ahajournals.org
Background—Recipients of left ventricular assist devices (LVADs) develop prominent B-cell
hyperreactivity. We investigated the influence of anti-HLA antibodies on waiting time to …
hyperreactivity. We investigated the influence of anti-HLA antibodies on waiting time to …
Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation
BA Pisani, GM Mullen, K Malinowska… - The Journal of heart and …, 1999 - Elsevier
BACKGROUND: Patients with a PRA> 10% are considered to be at greater risk for the
development of not only acute cellular and humoral rejection but also increased mortality …
development of not only acute cellular and humoral rejection but also increased mortality …
Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart …
S Itescu, TC Tung, EM Burke, A Weinberg, N Moazami… - Circulation, 1998 - ahajournals.org
Background—Preformed anti-HLA antibodies reacting specifically with donor lymphocytes
have been associated with acute vascular rejection and early cardiac allograft failure …
have been associated with acute vascular rejection and early cardiac allograft failure …